NCT00167245View on ClinicalTrials.gov

Topiramate for Alcohol and Cocaine Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

March 31, 2010

Study Completion Date

June 30, 2010

Conditions
AlcoholismCocaine Dependence
Interventions
DRUG

Topiramate

300mg/day for 13 weeks

DRUG

placebo

placebo pills

Trial Locations (1)

19104

University of Pennsylvania, Treatment Research Center, Philadelphia

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Kyle Kampman

OTHER

NCT00167245 - Topiramate for Alcohol and Cocaine Dependence | Biotech Hunter | Biotech Hunter